CLARET ASSET MANAGEMENT Corp »

Biogen Idec shares owned by CLARET ASSET MANAGEMENT Corp

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by CLARET ASSET MANAGEMENT Corp from 13F filings

Historical chart of CLARET ASSET MANAGEMENT Corp investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by CLARET ASSET MANAGEMENT Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by CLARET ASSET MANAGEMENT Corp

Quarter filed Position value Share count Share price at filing
2025-09-30 $257k 1.8k 139.83
2025-06-30 $234k 1.9k 125.54

More positions owned by CLARET ASSET MANAGEMENT Corp

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Cgi Cl A Sub Vtg (GIB)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Ollies Bargain Outlt Hldgs I (OLLI)
Ulta Salon, Cosmetics & Fragrance (ULTA)
Apple (AAPL)
North American Const (NOA)
Abbvie (ABBV)
Oaktree Specialty Lending Corp (OCSL)
CVS Caremark Corporation (CVS)
Indivior Ord (INDV)
Rbc Cad (RY)
Ubiquiti (UI)

View all positions for CLARET ASSET MANAGEMENT Corp

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
State Street Corporation
Point72 Asset Management
Wellington Management Company
Geode Capital Management
Invesco
Susquehanna International
Morgan Stanley
AQR Capital Management
Legal & General Group
Northern Trust
Millennium Management
Pacer Advisors

View all funds holding Biogen Idec